Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 125 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Barry B.

Canada

USD 125 /hr

Senior molecular biologist with a background in experimental oncology, mitochondria toxicology and environmental health.

Profile Summary

Barry J Barclay Ph D is President/CEO of SunHealthRx Inc. based in St Albert, Alberta Canada. Barry designed and was the first Coordinator of the After-degree Program in Environmental Health at Concordia University College of Alberta. Previously he held faculty appointments in Molecular Biology and/or Experimental Oncology at Cariboo College (now Thompson Rivers University), University of Alberta, Cross Cancer Institute, Brock University, York University, and the Department of Biochemical Pharmacology at the State University of New York at Buffalo.

Subject Matter Expertise

• ★ Skin Cancer
• ☆ Environmental Health
• ☆ Carcinogenesis

Services

• Writing
• Research

Writing Clinical Trial Documentation, Technical Writing, Newswriting

Research Fact Checking, Systematic Literature Review, Secondary Data Collection

Work Experience

President & CEO

SunHealthRx Inc

October 2016 - Present

President & CEO

Planet Biotech

June 1998 - Present

Education

Ph D (Biology)

York University

June 1975 - May 1978

BSc (hons)

York University

September 1971 - May 1975

Certifications

• Certification details not provided.

Publications

JOURNAL ARTICLE

(2018). Mitochondrial Correction: A New Paradigm for Cancer and Degenerative Diseases. Journal of Orthomolecular Medicine.

Narayanan KB, Ali M, Barclay BJ, Cheng QS, D'Abronzo L, Dornetshuber-Fleiss R, Ghosh PM, Gonzalez Guzman MJ, Lee TJ, Leung PS, Li L, Luanpitpong S, Ratovitski E, Rojanasakul Y, Romano MF, Romano S, Sinha RK, Yedjou C, Al-Mulla F, Al-Temaimi R, Carcinogenesis, 2015, vol. 36 Suppl 1, pp. S89-110 .

Goodson WH 3rd, Lowe L, Carpenter DO, Gilbertson M, Manaf Ali A, Lopez de Cerain Salsamendi A, Lasfar A, Carnero A, Azqueta A, Amedei A, Charles AK, Collins AR, Ward A, Salzberg AC, Colacci A, Olsen AK, Berg A, Barclay BJ, Zhou BP, Blanco-Aparicio C, Carcinogenesis, 2015, vol. 36 Suppl 1, pp. S254-96 .

Barclay BJ, DeHaan CL, Hennig UG, Iavorovska O, von Borstel RW, von Borstel RC, Environmental and molecular mutagenesis, 2001, vol. 38, no. 2-3, pp. 153-158 .

Barclay BJ, Nagel MG, Huang T, Advances in experimental medicine and biology, 1993, vol. 338, pp. 551-554 .

Barclay BJ, Ondrusek NK, Wildenhain YD, Huang T, Carlone RL, Clement JM, Wahl GM, Advances in experimental medicine and biology, 1993, vol. 338, pp. 545-550 .

Huang T, Barclay BJ, Kalman TI, von Borstel RC, Hastings PJ, Gene, 1992, vol. 121, no. 1, pp. 167-171 .

Barclay BJ, Huang T, Nagel MG, Misener VL, Game JC, Wahl GM, Gene, 1988, vol. 63, no. 2, pp. 175-185 .

Taylor GR, Barclay BJ, Storms RK, Friesen JD, Haynes RH, Molecular and cellular biology, 1982, vol. 2, no. 4, pp. 437-442 .

Barclay BJ, Kunz BA, Little JG, Haynes RH, Canadian journal of biochemistry, 1982, vol. 60, no. 3, pp. 172-184 .

Moens PB, Barclay BJ, Little JG, Chromosoma, 1981, vol. 82, no. 3, pp. 333-340 .

Kunz BA, Barclay BJ, Haynes RH, Mutation research, 1980, vol. 73, no. 1, pp. 215-220 .

Kunz BA, Barclay BJ, Game JC, Little JG, Haynes RH, Proceedings of the National Academy of Sciences of the United States of America, 1980, vol. 77, no. 10, pp. 6057-6061 .

Barclay BJ, Little JG, Molecular & general genetics : MGG, 1978, vol. 160, no. 1, pp. 33-40 .

Barclay BJ, Little JG, Journal of bacteriology, 1977, vol. 132, no. 3, pp. 1036-1037 .

CONFERENCE PAPER

(2017). Thymidylate Synthetase Dysregulation is a Molecular Switch and Tumorigenic Driver in Early Breast Cancer. Primary Therapy of Early Breast Cancer 15th St Gallen International Breast Cancer Conference.